Market Analysis of Global Pharmaceutical Industries and Trend Estimation Featuring Pfizer, J&J, Abbott, Gilead, Sun Pharma, GSK and Eli Lilly
Research and Markets has announced the addition of the "Market Analysis Of Global Pharmaceutical Industries And Trend Estimation" report to their offering.
The report analyses the global trend of pharmaceutical industries. It gives vivid profile of generic drugs and emerging market across the globe. A comprehensive market analysis of Germany, Russia, US, Australia, China and India has been presented. Analysis covers market capacity, market value, drug consumption, healthcare expenditure, export and import of drugs, retail commercial market, hospital sale, key achievements and developments, markets around different kinds of drugs etc. The report presents financial analysis of top pharmaceutical companies such as Pfizer, Johnson and Johnson, Abbott, Gilead, Sun Pharma, Glaxo Smith Kline, Eli Lilly & Company.
The latest annual reports of all companies were analysed and compared with earlier reports so as to decipher market trends. Key issues involved in pharmaceutical supply chain for optimization have been identified. Management, discussion and analysis reports of global pharmaceutical industries are an added feature of this report. The future global market trend for coming years has been predicted in light of enormous data collected from various sources.
Key Topics Covered:
1. Pharmaceutical And Pharmaceutical Company
1.1 Pharmaceutical Company
1.2 Definition Of Medicinal Product Or Drug
1.3 Classification Of Drugs
1.4 History Of Drugs
1.5 Ancient Pharmacology
1.6 Medieval Pharmacology
1.7 Modern Pharmacology
1.8 Drugs And Intellectual Property Rights
2. Generic Industry
2.1 Generic Industry
2.2 Introduction To The Generic Market
2.3 Leading Companies In The Generic Industry
2.4 The Generic Industry And Mergers & Acquisitions
2.5 Generic Industry & Emerging Markets
2.6 Conclusion To The Generics Industry
3. Pharmaceutical Industries In Selected Countries Of The World
3.1 German Pharmaceutical Industry
3.2 Russian Pharmaceutical Market
3.3 Russian Pharma Company
3.4 Russian Pharmaceuticals Market
3.5 Us Pharmaceuticals Market
3.6 Australia Pharmaceuticals Industry
3.7 China Pharmaceuticals Industry
3.8 Indian Pharmaceuticals Industry
4. Financial Analysis Of Top Pharmaceutical Companies
4.1 Pfizer
4.2 Johnson & Johnson
4.3 Abbott Pharmaceuticals
4.4 Gilead
4.5 Sun Pharma
4.6 Glaxo Smith Kline Annual Report
4.7 Eli Lilly & Company Annual Report
5. Pharmaceutical Supply Chains: Key Issues And Strategies For Optimisation
5.1 Trends In The Pharmaceutical And Related Industries
5.2 Value Chains
5.3 Supply Chains
5.4 Process, Development & Design
5.5 Optimised Planning Of Tests
5.6 Capacity And Portfolio Planning Under Uncertainty
5.7 Combined Testing And Capacity Planning
5.8 Classical Supply Chain Planning And Management
5.9 Issues/Structure
5.10 Dynamic Supply Chain Analysis
5.11 A Particular Market
5.12 Comparison Of Two Supply Chain Responses
5.13 Some Conclusions
5.14 Future Perspectives
6. Management, Discussion And Analysis Report Of Global Pharma Industry
7. Summary
Related News
-
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Pharma Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain. -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement. -
.png)
News BIOSECURE Act continues to loom over Chinese pharma manufacturers
With the US BIOSECURE Act on its way to passing into legislation, Chinese companies are facing declining revenues within the first half of 2024 as US pharmaceutical and healthcare companies pull their businesses from the country. -
.png)
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
.png)
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
.png)
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance